Scibase Holding Investor Relations Material
Latest events
CMD 2024
Scibase Holding
Q1 2025
13 May, 2025
Q4 2024
25 Feb, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Scibase Holding
Access all reports
SciBase Holding AB is a medical technology company specializing in the development and commercialization of point-of-care diagnostic platforms. These platforms, such as Nevisense and Nevisense Go, utilize electrical impedance spectroscopy (EIS) to assess skin disorders, including melanoma and non-melanoma skin cancers, as well as skin barrier function and inflammation. The company is headquartered in Sundbyberg, Sweden, and its shares are listed on the Nasdaq Stockholm.
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
SCIB
Country
🇸🇪 Sweden